Skip to main content

Table 4 ORs for T2DM, Pre-T2DM, and hyperglycemia in the outcome survey associated with the high–high group with the low–low group as reference, adjusting for covariates

From: Temporal relationship between inflammation and insulin resistance and their joint effect on hyperglycemia: the Bogalusa Heart Study

Independent variable Outcome
T2DM (37 vs 155) Pre-T2DM (89 vs 155) Hyperglycemia (126 vs 155)
OR (95% CI) p OR (95% CI) p OR (95% CI) p
Black race 1.14 (0.50–2.63) 0.758 0.98 (0.51–1.90) 0.953 1.07 (0.60–1.91) 0.823
Female sex 0.72 (0.30–1.73) 0.467 0.39 (0.21–0.72) 0.003 0.49 (0.28–0.84) 0.010
Age 1.05 (0.96–1.16) 0.286 1.10 (1.02–1.17) 0.010 1.08 (1.02–1.15) 0.011
BMI 1.07 (1.01–1.12) 0.014 1.09 (1.05–1.14) < 0.001 1.08 (1.04–1.12) < 0.001
Smoking 1.74 (0.71–4.25) 0.224 1.17 (0.59–2.32) 0.647 1.28 (0.70–2.34) 0.419
Alcohol drinking 0.30 (0.11–0.86) 0.025 1.06 (0.57–1.96) 0.855 0.77 (0.44–1.36) 0.367
Groupa 2.38 (1.06–5.33) 0.035 2.27 (1.27–4.05) 0.006 2.18 (1.30–3.64) 0.003
  1. High and low levels of baseline hsCRP and follow-up HOMA-IR were defined by their medians
  2. OR, odds ratio; CI, confidence interval; T2DM, type 2 diabetes mellitus; BMI, body mass index; hsCRP, high-sensitivity C-reactive protein; HOMA-IR, homeostasis model assessment for insulin resistance
  3. aCoding: high–high group = 1; low–low group = 0